{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:44:17Z","timestamp":1791582257127,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002706","name":"AFA F\u00f6rs\u00e4kring","doi-asserted-by":"publisher","award":["160266"],"award-info":[{"award-number":["160266"]}],"id":[{"id":"10.13039\/501100002706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-01065"],"award-info":[{"award-number":["2016-01065"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20160734"],"award-info":[{"award-number":["20160734"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myocardial infarction is a leading cause of death globally but is notoriously difficult to predict. We aimed to identify biomarkers of an imminent first myocardial infarction and design relevant prediction models. Here, we constructed a new case\u2013cohort consortium of 2,018 persons without prior cardiovascular disease from six European cohorts, among whom 420 developed a first myocardial infarction within 6 months after the baseline blood draw. We analyzed 817 proteins and 1,025 metabolites in biobanked blood and 16 clinical variables. Forty-eight proteins, 43 metabolites, age, sex and systolic blood pressure were associated with the risk of an imminent first myocardial infarction. Brain natriuretic peptide was most consistently associated with the risk of imminent myocardial infarction. Using clinically readily available variables, we devised a prediction model for an imminent first myocardial infarction for clinical use in the general population, with good discriminatory performance and potential for motivating primary prevention efforts.<\/jats:p>","DOI":"10.1038\/s44161-024-00422-2","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T11:02:36Z","timestamp":1707735756000},"page":"130-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Markers of imminent myocardial infarction"],"prefix":"10.1038","volume":"3","author":[{"given":"Stefan","family":"Gustafsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1946-7068","authenticated-orcid":false,"given":"Karin","family":"Jensevik Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-9015","authenticated-orcid":false,"given":"Adam S.","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6lve","family":"Elmst\u00e5hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Hveem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Langhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"L\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Metspalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conchi","family":"Moreno-Iribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Perola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Simell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmo","family":"Sipsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Olav","family":"\u00c5svold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Hammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ganna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil","family":"Svennblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-8454","authenticated-orcid":false,"given":"Johan","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"422_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095\u20132128 (2012).","journal-title":"Lancet"},{"key":"422_CR2","doi-asserted-by":"publisher","unstructured":"European Society of Cardiology, European Heart Network, European Commission, World Health Organization. European heart health charter. Eur. J. Prev. Cardiol. https:\/\/doi.org\/10.1097\/01.hjr.0000266926.91914.2a (2007).","DOI":"10.1097\/01.hjr.0000266926.91914.2a"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jamainternmed.2013.14558","volume":"174","author":"IM Carey","year":"2014","unstructured":"Carey, I. M. et al. Increased risk of acute cardiovascular events after partner bereavement: a matched cohort study. JAMA Intern. Med. 174, 598\u2013605 (2014).","journal-title":"JAMA Intern. Med."},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa1110307","volume":"366","author":"F Fang","year":"2012","unstructured":"Fang, F. et al. Suicide and cardiovascular death after a cancer diagnosis. N. Engl. J. Med. 366, 1310\u20131318 (2012).","journal-title":"N. Engl. J. Med."},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.amjcard.2012.03.008","volume":"110","author":"T Zaman","year":"2012","unstructured":"Zaman, T. et al. Angiographic lesion severity and subsequent myocardial infarction. Am. J. Cardiol. 110, 167\u2013172 (2012).","journal-title":"Am. J. Cardiol."},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","volume":"373","author":"K Kotseva","year":"2009","unstructured":"Kotseva, K. et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373, 929\u2013940 (2009).","journal-title":"Lancet"},{"key":"422_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/aje\/kwr374","volume":"175","author":"A Ganna","year":"2012","unstructured":"Ganna, A. et al. Risk prediction measures for case\u2013cohort and nested case\u2013control designs: an application to cardiovascular disease. Am. J. Epidemiol. 175, 715\u2013724 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI7362","volume":"104","author":"F Liang","year":"1999","unstructured":"Liang, F. & Gardner, D. G. Mechanical strain activates BNP gene transcription through a p38\/NF-\u03baB-dependent mechanism. J. Clin. Invest. 104, 1603\u20131612 (1999).","journal-title":"J. Clin. Invest."},{"key":"422_CR9","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A. et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145, e895\u2013e1032 (2022).","journal-title":"Circulation"},{"key":"422_CR10","first-page":"e368","volume":"144","author":"M Gulati","year":"2021","unstructured":"Gulati, M. et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 144, e368\u2013e454 (2021).","journal-title":"Circulation"},{"key":"422_CR11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jacc.2004.07.057","volume":"44","author":"MS Sabatine","year":"2004","unstructured":"Sabatine, M. S. et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J. Am. Coll. Cardiol. 44, 1988\u20131995 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/hmg\/ddw012","volume":"25","author":"A Johansson","year":"2016","unstructured":"Johansson, A. et al. Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. Hum. Mol. Genet. 25, 1447\u20131456 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","volume":"2","author":"L Folkersen","year":"2020","unstructured":"Folkersen, L. et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat. Metab. 2, 1135\u20131148 (2020).","journal-title":"Nat. Metab."},{"key":"422_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00011-021-01505-7","volume":"70","author":"H Rai","year":"2021","unstructured":"Rai, H. et al. Association of interleukin 6 \u2212174 G\/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysis. Inflamm. Res. 70, 1075\u20131087 (2021).","journal-title":"Inflamm. Res."},{"key":"422_CR15","doi-asserted-by":"publisher","first-page":"e021069","DOI":"10.1161\/JAHA.120.021069","volume":"10","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto, M. et al. HE4 predicts progressive fibrosis and cardiovascular events in patients with dilated cardiomyopathy. J. Am. Heart Assoc. 10, e021069 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"422_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbrc.2015.06.139","volume":"464","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., Si, Y., Ma, N. & Mei, J. The RNA-binding protein PCBP2 inhibits Ang II-induced hypertrophy of cardiomyocytes though promoting GPR56 mRNA degeneration. Biochem. Biophys. Res. Commun. 464, 679\u2013684 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"e017221","DOI":"10.1161\/JAHA.120.017221","volume":"9","author":"CP McCarthy","year":"2020","unstructured":"McCarthy, C. P. et al. Derivation and external validation of a high-sensitivity cardiac troponin-based proteomic model to predict the presence of obstructive coronary artery disease. J. Am. Heart Assoc. 9, e017221 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"422_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med. 23, 1158\u20131166 (2017).","journal-title":"Nat. Med."},{"key":"422_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/15563650.2013.844822","volume":"51","author":"DB Liss","year":"2013","unstructured":"Liss, D. B., Paden, M. S., Schwarz, E. S. & Mullins, M. E. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure? Clin. Toxicol. (Phila.) 51, 817\u2013827 (2013).","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"422_CR20","doi-asserted-by":"publisher","first-page":"107326","DOI":"10.1016\/j.intimp.2020.107326","volume":"92","author":"Y Deng","year":"2021","unstructured":"Deng, Y. et al. Upregulated microRNA-381-5p strengthens the effect of dexmedetomidine preconditioning to protect against myocardial ischemia\u2013reperfusion injury in mouse models by inhibiting CHI3L1. Int. Immunopharmacol. 92, 107326 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1471-2288-14-137","volume":"14","author":"T van der Ploeg","year":"2014","unstructured":"van der Ploeg, T., Austin, P. C. & Steyerberg, E. W. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med. Res. Methodol. 14, 137 (2014).","journal-title":"BMC Med. Res. Methodol."},{"key":"422_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbt.2018.10.001","volume":"49","author":"BA Simell","year":"2019","unstructured":"Simell, B. A. et al. Transnational access to large prospective cohorts in Europe: current trends and unmet needs. N. Biotechnol. 49, 98\u2013103 (2019).","journal-title":"N. Biotechnol."},{"key":"422_CR23","doi-asserted-by":"publisher","first-page":"e2128817","DOI":"10.1001\/jamanetworkopen.2021.28817","volume":"4","author":"A Sajja","year":"2021","unstructured":"Sajja, A. et al. Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw. Open 4, e2128817 (2021).","journal-title":"JAMA Netw. Open"},{"key":"422_CR24","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2018)."},{"key":"422_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"422_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren, S. & Groothuis-Oudshoorn, K. mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1\u201367 (2011).","journal-title":"J. Stat. Softw."},{"key":"422_CR27","doi-asserted-by":"crossref","unstructured":"Harrell, F. E. Jr. rms: regression modeling strategies. CRAN.R-project.org\/package=rms (2020).","DOI":"10.32614\/CRAN.package.rmsb"},{"key":"422_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v077.i01","volume":"77","author":"MN Wright","year":"2017","unstructured":"Wright, M. N. & Ziegler, A. ranger: a fast implementation of random forests for high dimensional data in C++ and R. J. Stat. Softw. 77, 1\u201317 (2017).","journal-title":"J. Stat. Softw."},{"key":"422_CR29","unstructured":"Therneau, T. A package for survival analysis in R. CRAN.R-project.org\/package=survival (2022)."},{"key":"422_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White, I. R., Royston, P. & Wood, A. M. Multiple imputation using chained equations: issues and guidance for practice. Stat. Med. 30, 377\u2013399 (2011).","journal-title":"Stat. Med."},{"key":"422_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin, D. B. Inference and missing data. Biometrika 63, 581\u2013592 (1976).","journal-title":"Biometrika"},{"key":"422_CR32","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/sim.8570","volume":"39","author":"PC Austin","year":"2020","unstructured":"Austin, P. C., Harrell, F. E. Jr. & van Klaveren, D. Graphical calibration curves and the integrated calibration index (ICI) for survival models. Stat. Med. 39, 2714\u20132742 (2020).","journal-title":"Stat. Med."},{"key":"422_CR33","doi-asserted-by":"crossref","unstructured":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42, 2439\u20132454 (2021).","DOI":"10.1093\/eurheartj\/ehab309"},{"key":"422_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.286.2.180","volume":"286","author":"RB D\u2019Agostino Sr.","year":"2001","unstructured":"D\u2019Agostino, R. B. Sr., Grundy, S., Sullivan, L. M. & Wilson, P. CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286, 180\u2013187 (2001).","journal-title":"JAMA"},{"key":"422_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/joim.12384","volume":"278","author":"G Bergstr\u00f6m","year":"2015","unstructured":"Bergstr\u00f6m, G. et al. The Swedish CArdioPulmonary BioImage Study: objectives and design. J. Intern. Med. 278, 645\u2013659 (2015).","journal-title":"J. Intern. Med."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00422-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00422-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00422-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T02:27:16Z","timestamp":1731292036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00422-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1038\/s44161-024-00422-2","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A.S.B. reports grants outside this work (from AstraZeneca, Bayer, Biogen, BioMarin, Bioverativ, Novartis and Sanofi) and personal fees from Novartis. E.I. is now an employee at GlaxoSmithKline. S.G. is an employee of Sence Research AB. J.S. reports stock ownership in Anagram kommunikation AB and Symptoms Europe AB outside the submitted work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}